Group Antenatal Care: Effectiveness and Contextual Factors Linked to Implementation Success in Malawi: Complete Statistical Analysis

1. Trial at a Glance

This page covers the registry results for Group Antenatal Care: Effectiveness and Contextual Factors Linked to Implementation Success in Malawi (NCT03673709), a randomized na study. The primary outcome is Born Weighing Less Than 2500 g.

2. Clinical Question

The trial is intended to compare an evidence-based group-care model with individual antenatal care. The registry frames the broader research as examining maternal, infant, and HIV-prevention outcomes, as well as contextual factors linked to implementation success. However, the record does not report an analyzed estimate for the listed primary endpoint, so it does not establish the direction or size of a difference between care approaches.

3. Trial Design

The registry describes a randomized, single-masked, parallel trial comparing group antenatal care with individual antenatal care. The record lists enrollment of 1887 and identifies 7 antenatal clinics in Blantyre District, Malawi. The sponsor is the University of Illinois Chicago. The trial status is completed, with a start date of 2019-07-05 and primary completion date of 2023-08-10. The phase is listed as NA.

In the group-care arm, women are described as having the same number of visits as those in individual care. Intake and the first postnatal visit are conducted individually, while other visits are described as 2-hour sessions with the same provider in a group of 8-12 women. In the usual-care arm, the registry describes first come, first serve visits, a health lecture, and an individual physical assessment with a midwife. It also mentions laboratory tests, including HIV testing, at the first visit. The arm descriptions in the registry record are incomplete, so further operational details are not reported in the registry record.

Randomization indicates that allocation to the care approaches was intended to be by chance, but the method used to generate or conceal allocation is not reported in the registry record. Although masking is recorded as single, the identity of the masked parties is not reported in the registry record. The record does not report the statistical analysis plan, sample-size justification, interim analyses, or how clinic-level structure was handled. The trial description therefore establishes the broad comparison and setting, but not the full design details needed to assess every design choice.

4. Participant Flow and Accounting

The registry reports how participants moved through each stage of the study. All counts below are exactly as posted; missing counts are not inferred from other stages.

Overall Study

5. Baseline Characteristics

The table reproduces the baseline characteristics posted in the registry, which describe the participants analysed at baseline and help show whether the randomized groups were comparable.

6. Primary Endpoint

The registry lists the primary outcome as Born Weighing Less Than 2500 g, measured over 8 weeks postpartum.

The listed primary endpoint is whether a newborn weighed less than 2500 g at birth, with the outcome assessed at 8 weeks postpartum. It is recorded as a participant count for a binary outcome: each newborn either meets the weight threshold or does not. The registry says this measure is used as a proxy for preterm birth because accurate gestational-age data were unavailable.

Birth weight and gestational age are different measures. In general, a proxy is used when the target concept cannot be measured directly or reliably, but it does not make the proxy identical to that target. The registry explains the reason for using this endpoint, but does not report information about how birth weight was measured, how missing birth-weight values were handled, or how the proxy’s performance was assessed in this trial.

The endpoint is clinically interpretable as a low-birth-weight threshold, but a result for this measure would not by itself identify gestational age at birth. The registry record lists no analyzed effect estimate, uncertainty interval, or test for the primary endpoint. It also notes that the primary outcome has several categories or time points and is not reduced to a single comparison in the posted analysis. Consequently, the endpoint definition can be described, but its comparative result cannot be interpreted from the registry record.

7. Why No Re-analysis Is Shown

8. Statistical Interpretation

9. Statistical Methods Explained

Randomization and the parallel design describe how the comparison was organized at a broad level. In general, random allocation is intended to reduce systematic differences between assigned groups at the start of a trial. A parallel design means the care approaches are compared across groups rather than each participant receiving both approaches in sequence. The registry does not report the randomization method, allocation concealment procedures, or the analysis model used for the primary endpoint.

What does a binary endpoint mean?

The endpoint is whether a newborn’s birth weight was below the stated threshold. A binary outcome records whether an event or condition occurred, rather than measuring a continuous range of values. For a group comparison, an analysis might report the number of participants meeting the endpoint and a measure of the contrast between groups. The registry describes the outcome as a participant count, but does not report the comparative estimate or the underlying analysis for this endpoint.

Why does the proxy matter?

The registry explicitly uses the birth-weight threshold as a proxy for preterm birth because accurate gestational-age data were unavailable. In general, a proxy can make an outcome measurable when the target is not directly available, but the proxy answers a related rather than identical question. Interpretation should therefore stay with the recorded birth-weight outcome and avoid treating it as a direct measurement of gestational age. The record does not report validation or sensitivity analyses for this proxy.

How should uncertainty be read?

In general, an estimate is more informative when accompanied by an uncertainty interval. A confidence interval conveys the range of values compatible with the data and analysis assumptions; it is not a guarantee that the true effect lies within that range. The width reflects statistical precision, while the interval’s location relates to the direction and magnitude of the estimated contrast. No endpoint estimate or confidence interval is reported in the registry record, so neither direction nor precision can be evaluated.

What can a significance test establish?

In general, a significance test evaluates the data relative to a null hypothesis and a specified statistical model. A p-value is not a measure of the probability that a treatment works, nor does it quantify clinical importance. It is interpreted alongside the effect estimate, uncertainty interval, design, and assumptions. The registry record does not report a test or p-value for the primary endpoint. No statistical plan is reported, so it is not possible to determine from the record which tests or model choices were prespecified.

What do the planning assumptions mean?

The record describes planning illustrations based on an observed effect, with a two-sided significance level of 0.05, equal allocation between the two arms, and a normal approximation. The planning effect is framed as a stated fraction of the observed effect. In general, such calculations estimate the sample size that a hypothetical study might need under those assumptions. They are planning illustrations, not observed power and not evidence that the completed trial had a particular probability of detecting an effect. Because no analyzed primary comparison is reported, the observed effect needed to interpret these illustrations is not available in the registry record.

For non-time-to-event outcomes, the record says the planning quantities are participants per arm for 80% power or other stated power levels; for time-to-event outcomes, it describes total event counts using the Schoenfeld method. These conventions describe how planning quantities are expressed, not trial findings. The registry does not report the sample-size justification used for the trial’s design, so the planning assumptions should not be mistaken for its original design rationale.

Over-dispersion is a general statistical concern when outcomes vary more than a model assumes. If ignored, uncertainty estimates can be too small, making results appear more precise than warranted. The registry does not report whether over-dispersion was assessed or relevant to the endpoint analysis. Similarly, the record does not report whether clinic clustering, repeated observations, or other dependencies were incorporated into an analysis model. These are questions for a full statistical analysis report, not details that can be inferred from the trial’s broad design description.

10. Multiplicity, Missing Data and Analysis Populations

The registry lists 16 outcome measures, including the primary endpoint and secondary outcomes such as spontaneous abortion, stillbirth, infant death, maternal death, anemia, family planning, exclusive breastfeeding, and the Self Reporting Questionnaire (SRQ). When a study examines multiple outcomes, time points, or categories, multiplicity can arise: repeated statistical testing can increase the chance of finding an apparently notable result by chance. In general, a prespecified analysis plan can clarify which outcomes and contrasts are primary and how multiplicity is handled.

The record reports 0 analyses and does not reduce the primary outcome to one comparison because it has several categories or time points. It does not report a multiplicity adjustment, a hierarchy of outcomes, or which contrasts were intended to be confirmatory. It is therefore not possible to assess how the listed outcomes or time points were handled statistically. The registry listing of an outcome should not be read as evidence that it was analyzed or that a result was obtained.

Missing-data handling is also not reported in the registry record. The record does not state the amount of missing primary-endpoint data, the reasons for missingness, the method used to handle it, or whether sensitivity analyses were conducted. These details matter because an analysis based only on participants with observed outcomes can be biased if outcome availability is related to group assignment or outcome status.

The analysis populations are not reported in the registry record. There is no description of whether the primary analysis followed randomized assignment, included participants as treated, or used another population definition. Without that information, readers cannot determine the analysis denominator or how departures from assigned care were handled. These gaps limit assessment of both the statistical evidence and the potential for bias.

11. Safety Results

The registry reports serious adverse events as affected participants divided by participants at risk.

Deaths

Other (non-serious) adverse events

Participants with at least one non-serious event at or above the registry's 0% reporting threshold.

The registry presents safety figures separately for women and infants in each care group. In the serious-event fields, the number affected is recorded as 0 for Individual Antenatal Care Women, Individual Antenatal Care Infants, Group Antenatal Care Women, and Group Antenatal Care Infants. The record also lists deaths as 0 for Individual Antenatal Care Women, 16 for Individual Antenatal Care Infants, 1 for Group Antenatal Care Women, and 22 for Group Antenatal Care Infants.

These are registry counts, not a comparative safety analysis. The record does not explain the event definitions, attribution rules, follow-up windows, or whether the death counts were considered related to care. A count of zero in a serious-event field should not be read as proof that no other adverse events occurred; it describes only the recorded field. The death counts should be kept distinct from the serious-event affected counts because the registry lists them separately and does not explain their relationship.

Counts alone do not show the comparative risk or its precision. The record does not report a statistical comparison or confidence interval for these safety figures. It also does not provide enough information to establish whether all participants were followed for the same duration or whether the counts reflect complete ascertainment. Interpretation should therefore remain descriptive and limited to the registry entries.

12. What the Result Does, and Does Not, Mean

The record establishes that the trial was designed as a randomized comparison of group antenatal care and individual antenatal care in Malawi, and identifies newborn weight below 2500 g as the primary endpoint. It also gives a reason for using that endpoint: accurate gestational-age data were unavailable, so birth weight was used as a proxy for preterm birth. Those details clarify the research question and the measure selected to address it.

The record does not report an analyzed primary-endpoint comparison. It therefore does not show whether the endpoint was more or less frequent in either group, how large a difference might have been, or how precisely any difference was estimated. This is not a finding of no difference. Nor does the completed status or enrollment figure substitute for an outcome analysis.

The broader trial aims concern maternal, infant, and HIV-prevention outcomes and implementation context. The registry lists several secondary outcomes, but does not include comparative results for them in the analysis information described. The safety entries are also descriptive counts without an accompanying comparison or uncertainty estimate. They cannot, on their own, establish a causal effect or quantify relative safety.

In general, conclusions about a randomized trial depend on the prespecified endpoint, the analysis population, the handling of missing data, the statistical model, and the uncertainty around the estimated effect. The registry record does not report these analysis details for the primary endpoint. Readers should distinguish the existence and design of the trial from the availability of results: the former are described, while the latter are insufficient for assessing the comparative outcome.

The practical statistical conclusion is narrow. The registry record identifies what was compared and what the primary outcome was intended to measure, but does not provide the results needed to judge the size, direction, or precision of that comparison. A full results report would be needed to answer those questions.

13. Why This Trial Matters Statistically

This trial raises a useful statistical issue: the outcome used to represent the clinical concept of interest is not the concept itself. The registry uses birth weight below 2500 g as a proxy for preterm birth because accurate gestational-age data were unavailable. That choice makes it especially important to describe results in terms of the measured endpoint and to avoid treating a proxy as a direct measurement of gestational age.

The setting also matters for interpretation of the design. The trial compares group and individual care across 7 antenatal clinics in Blantyre District. In general, clinic-based studies may require attention to similarities among participants seen in the same setting. The registry does not report whether or how clinic-level structure was reflected in the statistical analysis, so the impact of that design feature cannot be assessed from the record.

The trial’s stated scope extends beyond the primary endpoint to maternal, infant, HIV-prevention, and implementation outcomes. Multiple outcomes and time points can complicate interpretation when the analysis plan and multiplicity approach are unclear. The registry lists 16 outcome measures but reports 0 analyses, leaving no comparative results with which to assess those questions.

For biostatistical interpretation, the key distinction is between a clear research question and an available estimate. The record describes the comparison and endpoint, but does not provide an effect estimate or uncertainty interval. Without those, statistical precision and the direction or magnitude of any observed contrast cannot be judged. The record is informative about trial structure and outcome selection, while its analysis record is insufficient for evaluating comparative effectiveness.

14. Limitations

• The posted summary statistics are the only data these results rest on; patient-level data, full protocols and statistical analysis plans are not available.
• Recalculated results are simple, unadjusted calculations from posted summaries. They do not replace the sponsor's prespecified analysis.

The primary limitation for interpreting results is that the registry record reports 0 analyses and no comparative estimate for the primary endpoint. It identifies the endpoint but does not provide its group-specific results, uncertainty interval, or statistical test. The outcome is also flagged as having several categories or time points and is not reduced to one comparison, preventing a single primary contrast from being interpreted from the posted analysis.

The endpoint is a proxy for preterm birth rather than a direct gestational-age measure. The registry explains that accurate gestational-age data were unavailable, but does not report assessment of the proxy or details of birth-weight measurement. Further details about eligibility, outcome ascertainment, and the analysis population are not reported in the registry record.

Important design and analysis details are absent. The method for generating and concealing random allocation, the identity of the masked parties, the statistical analysis plan, clinic-level modeling, missing-data handling, multiplicity procedures, and sample-size justification are not reported in the registry record. The arm descriptions are incomplete, limiting the description of care delivery beyond the details that are recorded.

The safety entries provide counts but not definitions, attribution, follow-up windows, or comparative uncertainty. The record also does not explain the relation between the serious-event fields and the separately listed deaths. These limitations mean that neither the primary outcome nor the safety information supports a complete comparative interpretation from the registry record alone.

15. Related Tutorials

16. Related Statistical Calculators

17. Sources

• ClinicalTrials.gov: Group Antenatal Care: Effectiveness and Contextual Factors Linked to Implementation Success in Malawi — NCT03673709.
• Registry record last updated 2026-07-13; status last verified 2026-06.
• Results first posted 2026-07-13.
• Data retrieved from ClinicalTrials.gov on 2026-11-09.
• Group sizes, means, event counts and sponsor-reported p-values are reproduced as posted. Effect estimates, confidence intervals and p-values not attributed to the sponsor are independently calculated from the posted summary statistics.

18. Record Summary

NCT03673709 is a completed, randomized, single-masked, parallel trial sponsored by the University of Illinois Chicago. It compares group antenatal care with individual antenatal care at 7 clinics in Blantyre District, Malawi. The registry lists enrollment of 1887, a start date of 2019-07-05, and primary completion on 2023-08-10.

The primary endpoint is newborn weight below 2500 g at birth, assessed at 8 weeks postpartum and used as a proxy for preterm birth because accurate gestational-age data were unavailable. The registry lists 16 outcome measures and 0 analyses. It does not report an analyzed comparison for the primary endpoint, so the direction, magnitude, and precision of a group difference cannot be determined from the registry record.